Cargando…

Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review

SIMPLE SUMMARY: Endocrine therapy taken after primary breast cancer treatment helps prevent breast cancer recurrence. However, many women are unable to adhere to endocrine therapy. This review examines potentially modifiable factors that are associated with endocrine therapy adherence, which might h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toivonen, Kirsti I., Williamson, Tamara M., Carlson, Linda E., Walker, Lauren M., Campbell, Tavis S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794693/ https://www.ncbi.nlm.nih.gov/pubmed/33561076 http://dx.doi.org/10.3390/cancers13010107

Ejemplares similares

A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer
por: Toivonen, Kirsti I, et al.
Publicado: (2021)

Both “Vitamin L for Life” and “One Milligram of Satan”: A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer
por: Toivonen, Kirsti I., et al.
Publicado: (2021)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

The Chemo-Gut Study: A Cross-Sectional Survey Exploring Physical, Mental, and Gastrointestinal Health Outcomes in Cancer Survivors
por: Deleemans, Julie M., et al.
Publicado: (2022)

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
por: Lambert, Leah K., et al.
Publicado: (2018)

Systematic adaptation of the adherence improving self‐management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach
por: Janssen, Anna M., et al.
Publicado: (2022)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom
por: McGuinness, Serena, et al.
Publicado: (2022)

Hobson’s choice or a horned dilemma: a grounded theory on adherence to adjuvant endocrine therapy verified with breast cancer survivors
por: AlOmeir, Othman, et al.
Publicado: (2022)

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
por: Lee, Joo Yun, et al.
Publicado: (2018)

Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors
por: Sella, Tal, et al.
Publicado: (2023)

Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors
por: Uslu, Yasemin, et al.
Publicado: (2023)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence
por: Cahir, Caitriona, et al.
Publicado: (2023)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
por: Eraso, Yolanda
Publicado: (2019)

Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory
por: AlOmeir, Othman, et al.
Publicado: (2020)

Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review
por: Xiao, Hong, et al.
Publicado: (2018)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018)

Open to Exploration? Association of Personality Factors With Complementary Therapy Use After Breast Cancer Treatment
por: Toivonen, Kirsti I., et al.
Publicado: (2018)

Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain
por: Rash, Joshua A, et al.
Publicado: (2017)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore
por: Ali, Eskinder Eshetu, et al.
Publicado: (2017)

Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study
por: Xu, Lei, et al.
Publicado: (2019)

Web-Based Mindfulness Interventions for People With Physical Health Conditions: Systematic Review
por: Toivonen, Kirsti I, et al.
Publicado: (2017)

Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
por: Matthews, Anthony, et al.
Publicado: (2018)

The relationship between work-related outcomes and symptoms in early breast cancer survivors receiving adjuvant endocrine therapy
por: Nakao, Mayumi, et al.
Publicado: (2022)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
por: Stewart, Sarah-Jane F., et al.
Publicado: (2023)

Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis
por: Wang, Jiani, et al.
Publicado: (2022)

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review
por: Yussof, Izzati, et al.
Publicado: (2022)

The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
por: Jiang, Haoran, et al.
Publicado: (2022)

Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer
por: Shinn, Eileen H., et al.
Publicado: (2022)

Breast cancer survivors–supportive care needs: systematic review
por: Khajoei, Rahimeh, et al.
Publicado: (2023)

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review
por: Fernandes, Leonor, et al.
Publicado: (2020)

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
por: Uchino, J., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_upl5fto3vgf6iutp9rua96f48u